PlainRecalls
FDA Drug Moderate Class II Ongoing

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.

Reported: October 15, 2025 Initiated: September 16, 2025 #D-0006-2026

Product Description

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.

Reason for Recall

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Details

Recalling Firm
ACCORD HEALTHCARE, INC.
Units Affected
54,432 bottles
Distribution
Nationwide in the US
Location
Raleigh, NC

Frequently Asked Questions

What product was recalled?
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.. Recalled by ACCORD HEALTHCARE, INC.. Units affected: 54,432 bottles.
Why was this product recalled?
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 15, 2025. Severity: Moderate. Recall number: D-0006-2026.